GlassScriptPhysician profile
Eureka A Rigby
NPI 1184792368
$7,023.05
in general payments reported to CMS, 2019-2025
19 companies · $5,223 in 2025
The $5,223 reported for 2025 was more than what 99% of Physician Assistant providers received nationally (typical 2025 total: $183).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $192 · 2022: $626 · 2023: $494 · 2024: $489 · 2025: $5,223.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $3,600 · Food and Beverage: $1,772 · Travel and Lodging: $834.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $3,600.00 |
| Food and Beverage | $1,771.75 |
| Travel and Lodging | $833.65 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $5,599.57 | 2021-2025 | |
| Novo Nordisk INC | $227.61 | 2022-2025 | Ozempic, Rybelsus |
| Viiv Healthcare Company | $215.91 | 2023-2025 | Dovato, Apretude, Rukobia |
| Janssen Pharmaceuticals, INC | $177.42 | 2021-2022 | |
| Astrazeneca Pharmaceuticals LP | $145.99 | 2021-2025 | Breztri, Farxiga |
| Merck Sharp & Dohme LLC | $130.02 | 2021-2025 | Pifeltro, Delstrigo, Dificid |
| Exact Sciences Corporation | $101.71 | 2023-2025 | Cologuard Collection Kit, The Cologuard Plus Collection Kit |
| Pfizer INC. | $83.42 | 2022-2025 | |
| Abbott Laboratories | $51.74 | 2024 | Freestyle Libre 3 |
| Cranial Technologies, INC | $50.58 | 2022-2023 | Doc Band |
| Boehringer Ingelheim Pharmaceuticals, INC. | $43.93 | 2021-2022 | |
| Bayer Healthcare Pharmaceuticals INC. | $34.76 | 2024-2025 | |
| Gilead Sciences, INC. | $32.19 | 2023 | |
| Lilly USA, LLC | $31.98 | 2022-2024 | Zepbound, Mounjaro |
| Dexcom, INC. | $24.02 | 2023 | Dexcom G6 Transmitter |
Show all 19 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Organogenesis INC. | $20.22 | 2025 | Apligraf |
| Amgen INC. | $18.15 | 2022 | |
| Edwards Lifesciences Corporation | $17.04 | 2022 | |
| Glaxosmithkline, LLC. | $16.79 | 2024 | Arexvy, Shingrix |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Eureka Rigby listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.